128 results

• Taxotere Alopecia Side Effects Result in Lawsuit Over Permanent Hair Loss After Chemotherapy

  March 13, 2017

  Irvin Jackson

  After undergoing breast cancer chemotherapy with the drug Taxotere, a California woman has filed a lawsuit alleging Sanofi-Aventis failed to warn about the risk of permanent alopecia, providing false and misleading information that suggested hair would regrow following treatment.

• Information on Hair Loss from Taxotere to be Provided in Plaintiff Fact Sheet

  February 21, 2017

  Irvin Jackson

  A Plaintiff Fact Sheet has been approved for Taxotere lawsuits, which is designed to streamline the exchange of information about permanent hair loss experienced by women nationwide after exposure to the controversial breast cancer drug.

• Chemotherapy Hair Loss May Be Prevented By Scalp-Cooling Device: Study

  February 17, 2017

  Irvin Jackson

  A new study suggests that the use of cooling caps could decrease the risk of hair loss from chemotherapy, even as the number of lawsuits over permanent hair loss linked to Taxotere side effects continue to be filed.

• Taxotere Lawsuit Filing Procedures Streamlined with Master and Short Form Complaints

  February 14, 2017

  Austin Kirk

  The process for women to bring product lawsuits over continuing hair loss caused by Taxotere will be streamlined, with the filing of a Master Long Form Complaint and Short Form Complaint in the federal MDL, where hundreds of claims are being pursued against the drug maker for failing to warn consumers and the medical community.

• Taxotere Permanent Baldness Risk Withheld From Breast Cancer Patients, Doctors: Lawsuit

  February 2, 2017

  Irvin Jackson

  Sanofi-Aventis allegedly withheld information about the risk of permanent baldness from the breast cancer drug Taxotere, even though alternative treatments were just as effective and did not carry the same risk, according to one of the latest in a growing number of lawsuits being pursued by women nationwide.

• Taxotere Found To Have More Side Effects, Lower Survival Rate Than Tecentriq: Study

  January 25, 2017

  Irvin Jackson

  A new study raises questions about the safety and effectiveness of Taxotere, which underperformed in both survival rates and side effects when compared to Tecentriq for treatment of lung cancer.

• Lawsuit Alleges Taxotere Caused Permanent And Severe Alopecia Hair Loss

  January 13, 2017

  Irvin Jackson

  A Taxotere lawsuit indicates that a woman is still suffering from permanent and severe hair loss eight years after taking the chemotherapy drug to treat her breast cancer.

• One-Third Of Breast Cancer Patients Receive Unnecessary Treatment: Study

  January 12, 2017

  Martha Garcia

  Researchers warn that many women with breast cancer receive an over-diagnosis, indicating their condition is worse than it is, which could lead to harsh and unnecessary treatments.

• Taxotere Hair Loss Attorneys Appointed to Leadership Roles in Federal MDL

  January 4, 2017

  Austin Kirk

  A small group of attorneys have been appointed to leadership roles in the Taxotere hair loss lawsuits, who will take steps that benefit all women in the growing litigation over the chemotherapy drug.

• Taxotere Settlement Committees Appointed in Hair Loss Lawsuits

  December 19, 2016

  Austin Kirk

  Nine attorneys have been selected to form plaintiff and defense settlement committees who will confer and see if the growing litigation can be resolved before the cases have to go to trial.